FDA Grants IND Approval for Lomonitinib to Eilean Therapeutics
Eilean Therapeutics has announced that the US Food and Drug Administration (FDA) has cleared the IND for lomonitinib (ZE46-0134).
Lomonitinib | 11/06/2024 | By Aishwarya | 244
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy